Clinical Trials Browser

Recruiting × INDUSTRY × Observational × Clear all

NCT00571389 2026-03-18

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

Other solid neoplasm

Solid Tumor, Adult

NCT05363319 2026-03-18

CEMI-LUNG

Carcinoma, Non-Small-Cell Lung

NCT06803927 2026-03-18

DETECT-ME

Gastrointestinal

Barrett Esophagus

NCT06833853 2026-03-18

CTC-EXPRESS

Breast Neoplasms

NCT05170815 2026-03-17

ErYs

Spinal Cord Neoplasms, Spinal Fractures

NCT06973161 2026-03-17

ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

GastrointestinalGenitourinaryGynecologicThoracic

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT04165798 2026-03-16

MK-3475-U01

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT05102110 2026-03-16

ORI-EGI-03

GastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT06610539 2026-03-16

MAGProm

Breast Neoplasms

NCT06930859 2026-03-16

ELEGANCE

Breast Neoplasms

NCT06299540 2026-03-13

QOLIBRI

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06909253 2026-03-13

MG-ARCADIA

Myasthenia Gravis

NCT07230691 2026-03-13

LEPIDOPTERA

Carcinoma, Non-Small-Cell Lung

NCT07247279 2026-03-13

Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

Myasthenia Gravis, Rare Diseases

NCT07309445 2026-03-13

Nova-sTAR

Non-Muscle Invasive Bladder Neoplasms

NCT05160584 2026-03-12

MoMMent

Multiple Myeloma

NCT05189639 2026-03-12

A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06285318 2026-03-12

REALiTEC/TAL

Multiple Myeloma

NCT06334120 2026-03-12

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

Non-metastatic Castration-resistant Prostate Cancer

NCT06376097 2026-03-12

Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.

Lung Neoplasms

NCT07466602 2026-03-12

cfDNA Methylation for Liver Cancer Recurrence Detection

Gastrointestinal

Carcinoma, Hepatocellular

NCT06902545 2026-03-11

A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

Adenocarcinoma, Neoplasms

NCT07046260 2026-03-11

PROCARES

Disease, Neoplasms

NCT07219277 2026-03-11

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening

Breast Neoplasms

NCT07143669 2026-03-10

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

MyeloidOther hematologic neoplasm

Mastocytosis, Leukemia, Myelomonocytic, Chronic, Postural Orthostatic Tachycardia Syndrome

NCT06486454 2026-03-09

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07459062 2026-03-09

SPCTR-I

Breast Neoplasms

NCT06862869 2026-03-06

Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy

Carcinoma, Non-Small-Cell Lung

NCT00196742 2026-03-05

Fabry Disease Registry & Pregnancy Sub-registry

Angiokeratoma, Fabry Disease

NCT05376891 2026-03-05

Met Non Small Cell Cancer Registry (MOMENT)

Neoplasms

NCT07290270 2026-03-05

PSMAreal

Prostatic Neoplasms

NCT05640102 2026-03-04

Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia

Waldenstrom Macroglobulinemia

NCT06163534 2026-03-04

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Squamous Cell Carcinoma of Head and Neck, Neoplasms

NCT07200375 2026-03-04

GlofitReal

Lymphoma, Large B-Cell, Diffuse

NCT07211178 2026-03-04

GEMINI Breast

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT06068049 2026-03-03

OSIREAL

Carcinoma, Non-Small-Cell Lung

NCT06830720 2026-03-03

CAROLEEN

Breast Neoplasms

NCT07028489 2026-03-03

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT07154823 2026-03-03

Aquarius

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT04142437 2026-03-02

ON-TRK

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

NCT06995833 2026-03-02

Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance

Endometrial Neoplasms

NCT07143110 2026-03-02

LUNG-ROLL

60,000 enrolled

Lung Neoplasms

NCT04830709 2026-02-27

SCOUT-1

Ovarian Neoplasms

NCT05573893 2026-02-27

PROVIDENCE

Breast Neoplasms, Neoplasm Metastasis

NCT06793709 2026-02-27

A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy

Gastrointestinal

Biliary Tract Neoplasms, Neoplasms

NCT07035886 2026-02-27

A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea

Gastrointestinal

Colorectal Neoplasms

NCT07284121 2026-02-27

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

GastrointestinalThoracic

Carcinoma, Hepatocellular, Lung Neoplasms

NCT07314164 2026-02-27

Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment

Neuroendocrine Tumors

NCT06207032 2026-02-24

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

Neoplasms

NCT07038928 2026-02-24

RIVERS

Urinary Bladder Neoplasms